Oleksandr Korotych

5 ta ish

World Health Organization Regional Office for Europe

1. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

   Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20213 iqtibos

   ABIABI:AkademIndex/2026.other.262609

2. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

   Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

   ABIABI:AkademIndex/2021.article.000207

3. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

   Jamshid Gadoev, Damin Asadov, Anthony Harries +11

   MaqolaOAOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

   ABIABI:AkademIndex/2021.article.000489

4. Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan

   Jamshid Gadoev, Anthony Harries, Oleksandr Korotych +7

   Tahririyat maqolasiOAOchiq kirishDiverse Scientific Research StudiesInternational Journal of Environmental Research and Public Health20210 iqtibos

   ABIABI:AkademIndex/2021.editorial.000002

5. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study

   Oleksandr Korotych, Jay Achar, Elmira Gurbanova +23

   PreprintOAOchiq kirishTuberculosis Research and EpidemiologySSRN Electronic Journal20240 iqtibos

   ABIABI:AkademIndex/2024.preprint.000046